Liliana Devizzi

TL;DR: Age, PS, LDH serum level, CSF protein concentration, and involvement of deep structures of the brain were independent predictors of survival and a prognostic score including these five parameters seems advisable in distinguishing different risk groups in PCNSL patients.

TL;DR: To assess the prognosis of peripheral T-cell lymphoma unspecified, retrospectively analyzed 385 cases fulfilling the criteria defined by the World Health Organization classification and constructed a new prognostic model that singled out 4 groups at different risk.

TL;DR: The data confirm the indolent nature of nongastric MALT lymphomas and the high rate of patients presenting with disseminated disease, which, when limited to mucosal sites, was not associated with a poorer outcome.

TL;DR: It is indicated that rituximab is safe with significant activity in MALT lymphomas with a response rate significantly higher in the chemotherapy-naive patients, who had an 87% response rate compared with 45% of the previously treated patients.

TL;DR: Gemcitabine was shown to be active in heavily pretreated patients with Hodgkin's disease, producing a response rate of 39%.